Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

This trial is testing whether adding a drug called cromoglicate (an anti-inflammatory medication) to existing antipsychotic treatment can further reduce symptoms in people with schizophrenia or schizoaffective disorder. Cromoglicate may help by reducing inflammation in the brain. **You may be eligible if...** - You are between 18 and 60 years old (any gender) - You have been diagnosed with schizophrenia or schizoaffective disorder - You have been on the same antipsychotic medication at a stable dose for at least one month - You still have significant symptoms (a total PANSS score of 60 or more, with at least one positive symptom rated 4 or above) **You may NOT be eligible if...** - You have recently changed your antipsychotic medication or dose - You are outside the 18–60 age range - You have severe medical conditions that would make participation unsafe Talk to your doctor to see if this trial is right for you.